Skip to main content
Jeffrey Heier, MD, Ophthalmology, Boston, MA

Jeffrey S Heier MD

Retinal Disease


Assistant Professor, Ophthalmology, Tufts Medical Center

Join to View Full Profile
  • 50 Staniford StSte 600Boston, MA 02114

  • Phone+1 617-367-4800

  • Fax+1 617-723-7028

Dr. Heier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Fitzsimons Army Medical Center
    Fitzsimons Army Medical CenterResidency, Ophthalmology, 1991 - 1994
  • Fitzsimons Army Medical Center
    Fitzsimons Army Medical CenterInternship, Transitional Year, 1989 - 1990
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1989

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1996 - 2026
  • RI State Medical License
    RI State Medical License 1998 - 2004
  • PA State Medical License
    PA State Medical License 1993 - 1998
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012-2017
  • CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012-2017
  • CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Aflibercept 8 Mg Shows Long-Term Efficacy in Diabetic Macular Edema with Fewer Injections, Shows Trial
    Aflibercept 8 Mg Shows Long-Term Efficacy in Diabetic Macular Edema with Fewer Injections, Shows TrialAugust 26th, 2025
  • Pivotal Data Validates Diagnostic Equivalence of SCANLY Home OCT and in-Office OCT in Wet AMD Management
    Pivotal Data Validates Diagnostic Equivalence of SCANLY Home OCT and in-Office OCT in Wet AMD ManagementJuly 9th, 2025
  • OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
    OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025June 23rd, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: